Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Youngil Pharm is a South Korean pharmaceutical company founded in 1978 that specializes in the development, manufacturing, and distribution of prescription and over-the-counter medications. The company maintains a robust portfolio focusing on therapeutic areas such as cardiovascular, digestive, and metabolic disorders, as well as antibiotics and anti-inflammatory agents. Youngil Pharm operates a high-standard manufacturing facility in Hwaseong, Gyeonggi-do, which is compliant with Good Manufacturing Practice (GMP) regulations. In addition to its proprietary product line, the company provides contract manufacturing (CMO) services to various domestic and international pharmaceutical partners. Youngil Pharm is recognized for its commitment to providing high-quality generic drugs and improving public health through continuous research and development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Youngil Pharm.